Submit Deal

BLUEWHALE BIO

Summary

BlueWhale Bio is a new company spun out of the University of Pennsylvania to overcome key bottlenecks in cell and gene therapy manufacturing.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 14 M

Avg. Deal Size£ 14 M

Market Context

Senior Management

Sort

Target: BLUEWHALE BIO

Bidder: DANAHER CORPORATION

5 Service Providers

7 Dealmakers

£ 14 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy